Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Gynecol Oncol. 2015 Jan 21;137(1):7–13. doi: 10.1016/j.ygyno.2015.01.535

Table 2.

Screening results

Pre Em-USP (n=395) Em-USP (n=242)
IHC screen performed (%)* 141 (36) 234 (97)
IHC concerning for LS 20 22
 MLH1 2 2
 MLH1/PMS2 20 29
 MSH6/MLH1 1 0
 MSH6/PMS2/MLH1 1 1
  MLH1 methylation referral (%) * 12 (50) 32 (100)
  MLH1 methylation present* 10 29
 PMS2 1 8
 MSH2 0 1
 MSH6 3 3
 MSH2/MSH6 4 5
 MSH6/PMS2 0 1
*

, p-value < 0.001

IHC, Immunohistochemistry